Clearmind Medicine Inc. SEC filings CMND
Clearmind Medicine Inc. has 372 filings in SEC EDGAR's recent list, going back to Dec 23, 2021. Its latest annual report, Form 20-F, was filed on Jan 20, 2026 for the period ended Oct 31, 2025. The most recent current report (Form 6-K) was filed on Oct 27, 2026. The company's fiscal year ends on October 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 27, 2026 | — |
| 6-K | Current report (foreign issuer) | Oct 27, 2026 | Oct 27, 2026 |
| 6-K | Current report (foreign issuer) | Oct 16, 2026 | Oct 16, 2026 |
| 6-K | Current report (foreign issuer) | Oct 13, 2026 | Oct 13, 2026 |
| 6-K | Current report (foreign issuer) | Oct 8, 2026 | Oct 8, 2026 |
| 6-K | Current report (foreign issuer) | Oct 7, 2026 | Oct 7, 2026 |
| 6-K | Current report (foreign issuer) | Sep 30, 2026 | Sep 30, 2026 |
| 6-K | Current report (foreign issuer) | Sep 23, 2026 | Sep 23, 2026 |
| 6-K | Current report (foreign issuer) | Sep 17, 2026 | Sep 17, 2026 |
| 6-K | Current report (foreign issuer) | Sep 14, 2026 | Sep 14, 2026 |
| 6-K | Current report (foreign issuer) | Sep 10, 2026 | Jul 31, 2026 |
| 6-K | Current report (foreign issuer) | Sep 8, 2026 | Sep 8, 2026 |
| 6-K | Current report (foreign issuer) | Sep 4, 2026 | Sep 4, 2026 |
| 6-K | Current report (foreign issuer) | Sep 2, 2026 | Sep 2, 2026 |
| 6-K | Current report (foreign issuer) | Sep 1, 2026 | Sep 1, 2026 |
| 6-K | Current report (foreign issuer) | Aug 24, 2026 | Aug 24, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 12, 2026 | — |
| 6-K | Current report (foreign issuer) | Aug 11, 2026 | Aug 11, 2026 |
| 6-K | Current report (foreign issuer) | Aug 6, 2026 | Aug 6, 2026 |
| 6-K | Current report (foreign issuer) | Aug 3, 2026 | Aug 3, 2026 |
| 6-K | Current report (foreign issuer) | Jul 30, 2026 | Jul 30, 2026 |
| 6-K | Current report (foreign issuer) | Jul 20, 2026 | Jul 20, 2026 |
| 6-K | Current report (foreign issuer) | Jul 17, 2026 | Jul 17, 2026 |
| 6-K | Current report (foreign issuer) | Jul 16, 2026 | Jul 16, 2026 |
| 6-K | Current report (foreign issuer) | Jul 13, 2026 | Jul 13, 2026 |
| 6-K | Current report (foreign issuer) | Jul 10, 2026 | Jul 10, 2026 |
| 6-K | Current report (foreign issuer) | Jul 7, 2026 | Jul 7, 2026 |
| 6-K | Current report (foreign issuer) | Jun 29, 2026 | Jun 29, 2026 |
| 6-K | Current report (foreign issuer) | Jun 22, 2026 | Jun 22, 2026 |
| EFFECT | Filing | Jun 18, 2026 | — |
| 4 | Insider transaction | Jun 18, 2026 | Jun 10, 2026 |
| 6-K | Current report (foreign issuer) | Jun 18, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 16, 2026 | Jun 10, 2026 |
| 6-K | Current report (foreign issuer) | Jun 16, 2026 | Jun 16, 2026 |
| POS AM | Post-effective amendment no. 3 to form f-1 | Jun 15, 2026 | — |
| 6-K | Current report (foreign issuer) | Jun 15, 2026 | Apr 30, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 3 | Initial insider ownership | Jun 12, 2026 | Jun 10, 2026 |
| 6-K | Current report (foreign issuer) | Jun 12, 2026 | Jun 12, 2026 |
| 6-K | Current report (foreign issuer) | Jun 1, 2026 | Jun 1, 2026 |
| 6-K | Current report (foreign issuer) | May 29, 2026 | May 29, 2026 |
| 6-K | Current report (foreign issuer) | May 26, 2026 | May 26, 2026 |
| 6-K | Current report (foreign issuer) | May 19, 2026 | May 19, 2026 |
| 6-K | Current report (foreign issuer) | May 19, 2026 | May 19, 2026 |
| 6-K | Current report (foreign issuer) | May 18, 2026 | May 18, 2026 |
| 6-K | Current report (foreign issuer) | May 18, 2026 | May 18, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 6-K | Current report (foreign issuer) | May 12, 2026 | May 12, 2026 |
| EFFECT | Filing | May 7, 2026 | — |
| CORRESP | Letter to the SEC | May 6, 2026 | — |
| UPLOAD | Letter from the SEC | May 6, 2026 | — |
| 6-K | Current report (foreign issuer) | May 5, 2026 | May 5, 2026 |
| F-3 | Shelf registration (foreign issuer) | Apr 30, 2026 | — |
| 6-K | Current report (foreign issuer) | Apr 30, 2026 | Apr 30, 2026 |
| 6-K | Current report (foreign issuer) | Apr 27, 2026 | Apr 27, 2026 |
| 6-K | Current report (foreign issuer) | Apr 21, 2026 | Apr 21, 2026 |
| 6-K | Current report (foreign issuer) | Apr 20, 2026 | Apr 20, 2026 |
| 6-K | Current report (foreign issuer) | Apr 20, 2026 | Apr 20, 2026 |
| 6-K | Current report (foreign issuer) | Apr 15, 2026 | Apr 15, 2026 |
| 6-K | Current report (foreign issuer) | Apr 15, 2026 | Apr 15, 2026 |
| 6-K | Current report (foreign issuer) | Apr 14, 2026 | Apr 14, 2026 |
| 6-K | Current report (foreign issuer) | Apr 14, 2026 | Apr 14, 2026 |
| EFFECT | Filing | Mar 30, 2026 | — |
| EFFECT | Filing | Mar 30, 2026 | — |
| 6-K | Current report (foreign issuer) | Mar 30, 2026 | Mar 30, 2026 |
| 6-K | Current report (foreign issuer) | Mar 27, 2026 | Mar 27, 2026 |
| POS AM | Post-effective amendment no. 9 to form f-1 | Mar 25, 2026 | — |
| POS AM | Post-effective amendment no. 9 to form f-1 | Mar 25, 2026 | — |
| 6-K | Current report (foreign issuer) | Mar 19, 2026 | Mar 19, 2026 |
| 6-K | Current report (foreign issuer) | Mar 17, 2026 | Mar 17, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 16, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 16, 2026 | — |
| 6-K | Current report (foreign issuer) | Mar 13, 2026 | Mar 13, 2026 |
| 6-K | Current report (foreign issuer) | Mar 12, 2026 | Jan 31, 2026 |
| 6-K | Current report (foreign issuer) | Mar 11, 2026 | Mar 11, 2026 |
| 6-K | Current report (foreign issuer) | Mar 10, 2026 | Mar 10, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 9, 2026 | — |
| 6-K | Current report (foreign issuer) | Mar 4, 2026 | Mar 4, 2026 |
| EFFECT | Filing | Feb 26, 2026 | — |
| CORRESP | Letter to the SEC | Feb 25, 2026 | — |
| UPLOAD | Letter from the SEC | Feb 25, 2026 | — |
| F-3 | Shelf registration (foreign issuer) | Feb 17, 2026 | — |
| 6-K | Current report (foreign issuer) | Feb 17, 2026 | Feb 17, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| 6-K | Current report (foreign issuer) | Feb 11, 2026 | Feb 11, 2026 |
| 6-K | Current report (foreign issuer) | Feb 9, 2026 | Feb 9, 2026 |
| 6-K | Current report (foreign issuer) | Feb 6, 2026 | Feb 6, 2026 |
| 6-K | Current report (foreign issuer) | Feb 4, 2026 | Feb 4, 2026 |
| 6-K | Current report (foreign issuer) | Feb 3, 2026 | Feb 3, 2026 |
| EFFECT | Filing | Jan 30, 2026 | — |
| EFFECT | Filing | Jan 30, 2026 | — |
| EFFECT | Filing | Jan 30, 2026 | — |
| POS AM | Post-effective amendment no. 8 to form f-1 | Jan 27, 2026 | — |
| POS AM | Post-effective amendment no. 8 to form f-1 | Jan 27, 2026 | — |
| POS AM | Post-effective amendment no. 1 to form f-1 | Jan 27, 2026 | — |
| 20-F | Annual report (foreign issuer) | Jan 20, 2026 | Oct 31, 2025 |
| 6-K | Current report (foreign issuer) | Jan 14, 2026 | Jan 14, 2026 |
| 6-K | Current report (foreign issuer) | Dec 31, 2025 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Dec 29, 2025 | Dec 29, 2025 |
| 6-K | Current report (foreign issuer) | Dec 16, 2025 | Dec 16, 2025 |
| 6-K | Current report (foreign issuer) | Dec 12, 2025 | Dec 12, 2025 |
| 6-K | Current report (foreign issuer) | Dec 12, 2025 | Dec 12, 2025 |
| 6-K | Current report (foreign issuer) | Dec 10, 2025 | Dec 10, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Dec 10, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Dec 10, 2025 | — |
| EFFECT | Filing | Dec 9, 2025 | — |
| CORRESP | Letter to the SEC | Dec 8, 2025 | — |
| 6-K | Current report (foreign issuer) | Dec 5, 2025 | Dec 5, 2025 |
| F-1/A | Amendment no. 1 to form f-1 | Dec 5, 2025 | — |
| 6-K | Current report (foreign issuer) | Dec 5, 2025 | Dec 5, 2025 |
| 6-K | Current report (foreign issuer) | Dec 3, 2025 | Dec 3, 2025 |
| 424B5 | Prospectus supplement | Dec 3, 2025 | — |
| 6-K | Current report (foreign issuer) | Dec 2, 2025 | Dec 2, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 1, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 1, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 28, 2025 | — |
| 6-K | Current report (foreign issuer) | Nov 28, 2025 | Nov 28, 2025 |
| F-1 | Registration statement (foreign issuer) | Nov 26, 2025 | — |
| 6-K | Current report (foreign issuer) | Nov 26, 2025 | Nov 26, 2025 |
| 424B5 | Prospectus supplement | Nov 26, 2025 | — |
| 6-K | Current report (foreign issuer) | Nov 25, 2025 | Nov 25, 2025 |
| 6-K | Current report (foreign issuer) | Nov 24, 2025 | Nov 24, 2025 |
| 6-K | Current report (foreign issuer) | Nov 20, 2025 | Nov 20, 2025 |
| 6-K | Current report (foreign issuer) | Nov 19, 2025 | Nov 19, 2025 |
| 424B5 | Prospectus supplement | Nov 19, 2025 | — |
| 6-K | Current report (foreign issuer) | Nov 18, 2025 | Nov 18, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 18, 2025 | — |
| 6-K | Current report (foreign issuer) | Nov 17, 2025 | Nov 17, 2025 |
| 6-K | Current report (foreign issuer) | Nov 17, 2025 | Nov 17, 2025 |
| 424B5 | Prospectus supplement | Nov 17, 2025 | — |
| 6-K | Current report (foreign issuer) | Nov 13, 2025 | Nov 13, 2025 |
| 6-K | Current report (foreign issuer) | Nov 13, 2025 | Nov 13, 2025 |
| 424B5 | Prospectus supplement | Nov 13, 2025 | — |
| 6-K | Current report (foreign issuer) | Nov 12, 2025 | Nov 12, 2025 |
| 6-K | Current report (foreign issuer) | Nov 6, 2025 | Nov 6, 2025 |
| 6-K | Current report (foreign issuer) | Nov 5, 2025 | Nov 5, 2025 |
| 6-K | Current report (foreign issuer) | Oct 31, 2025 | Oct 31, 2025 |
| 6-K | Current report (foreign issuer) | Oct 30, 2025 | Oct 30, 2025 |
| 6-K | Current report (foreign issuer) | Oct 27, 2025 | Oct 27, 2025 |
| 6-K | Current report (foreign issuer) | Oct 21, 2025 | Oct 21, 2025 |
| 6-K | Current report (foreign issuer) | Oct 20, 2025 | Oct 20, 2025 |
| EFFECT | Filing | Sep 30, 2025 | — |
| CORRESP | Letter to the SEC | Sep 30, 2025 | — |
| 6-K | Current report (foreign issuer) | Sep 25, 2025 | Sep 25, 2025 |
| UPLOAD | Letter from the SEC | Sep 24, 2025 | — |
| EFFECT | Filing | Sep 19, 2025 | — |
| F-1 | Registration statement (foreign issuer) | Sep 19, 2025 | — |
| 6-K | Current report (foreign issuer) | Sep 19, 2025 | Sep 19, 2025 |
| 6-K | Current report (foreign issuer) | Sep 17, 2025 | Sep 17, 2025 |
| POS AM | Post-effective amendment no.7 to form f-1 | Sep 15, 2025 | — |
| 6-K | Current report (foreign issuer) | Sep 11, 2025 | Jul 31, 2025 |
| 6-K | Current report (foreign issuer) | Aug 7, 2025 | Aug 7, 2025 |
| 6-K | Current report (foreign issuer) | Aug 5, 2025 | Aug 5, 2025 |
| 6-K | Current report (foreign issuer) | Jul 30, 2025 | Jul 30, 2025 |
| 6-K | Current report (foreign issuer) | Jul 29, 2025 | Jul 29, 2025 |
| 6-K | Current report (foreign issuer) | Jul 15, 2025 | Jul 15, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 3, 2025 | — |
| 6-K | Current report (foreign issuer) | Jul 3, 2025 | Jul 3, 2025 |
| 6-K | Current report (foreign issuer) | Jun 30, 2025 | Jun 30, 2025 |
| 6-K | Current report (foreign issuer) | Jun 27, 2025 | Jun 27, 2025 |
| 6-K | Current report (foreign issuer) | Jun 23, 2025 | Jun 23, 2025 |
| EFFECT | Filing | Jun 18, 2025 | — |
| POS AM | Post-effective amendment no. 6 to form f-1 | Jun 12, 2025 | — |
| 6-K | Current report (foreign issuer) | Jun 12, 2025 | Apr 30, 2025 |
| 6-K | Current report (foreign issuer) | Jun 12, 2025 | Jun 12, 2025 |
| 6-K | Current report (foreign issuer) | Jun 5, 2025 | Jun 5, 2025 |
| 6-K | Current report (foreign issuer) | May 12, 2025 | May 12, 2025 |
| 6-K | Current report (foreign issuer) | Apr 25, 2025 | Apr 25, 2025 |
| 6-K | Current report (foreign issuer) | Apr 23, 2025 | Apr 23, 2025 |
| 6-K | Current report (foreign issuer) | Apr 17, 2025 | Apr 17, 2025 |
| 6-K | Current report (foreign issuer) | Apr 10, 2025 | Apr 10, 2025 |
| 6-K | Current report (foreign issuer) | Apr 8, 2025 | Apr 8, 2025 |
| 6-K | Current report (foreign issuer) | Apr 1, 2025 | Apr 1, 2025 |
| 6-K | Current report (foreign issuer) | Mar 24, 2025 | Mar 24, 2025 |
| 6-K | Current report (foreign issuer) | Mar 19, 2025 | Mar 19, 2025 |
| 6-K | Current report (foreign issuer) | Mar 18, 2025 | Mar 18, 2025 |
| EFFECT | Filing | Mar 17, 2025 | — |
| POS AM | Post-effective amendment no. 5 to form f-1 | Mar 13, 2025 | — |
| 6-K | Current report (foreign issuer) | Mar 13, 2025 | Jan 31, 2025 |
| 6-K | Current report (foreign issuer) | Mar 10, 2025 | Mar 10, 2025 |
| EFFECT | Filing | Feb 18, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 6-K | Current report (foreign issuer) | Feb 4, 2025 | Feb 4, 2025 |
| POS AM | Post-effective amendment no. 4 to form f-1 | Jan 22, 2025 | — |
| 20-F | Annual report (foreign issuer) | Jan 22, 2025 | Oct 31, 2024 |
| 6-K | Current report (foreign issuer) | Jan 7, 2025 | Jan 7, 2025 |
| 6-K | Current report (foreign issuer) | Jan 6, 2025 | Jan 6, 2025 |
| 6-K | Current report (foreign issuer) | Jan 2, 2025 | Jan 2, 2025 |
| 6-K | Current report (foreign issuer) | Dec 26, 2024 | Dec 26, 2024 |
| S-8 | Employee stock plan registration | Dec 9, 2024 | — |
| 6-K | Current report (foreign issuer) | Dec 6, 2024 | Dec 6, 2024 |
| 6-K | Current report (foreign issuer) | Nov 20, 2024 | Nov 20, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 6-K | Current report (foreign issuer) | Oct 10, 2024 | Oct 10, 2024 |
| EFFECT | Filing | Sep 30, 2024 | — |
| 6-K | Current report (foreign issuer) | Sep 26, 2024 | Sep 26, 2024 |
| POS AM | Post-effective amendment no. 3 to form f-1 | Sep 24, 2024 | — |
| 6-K | Current report (foreign issuer) | Sep 16, 2024 | Sep 16, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CMND (Nasdaq)
- Fiscal year ends
- October 31
- Incorporated in
- Canada (Federal Level)
- Headquarters
- Vancouver, British Columbia, Canada (Federal Level)
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1892500
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.